Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026)

Koninklijke Philips' (PHG) quarterly Net Income towards Common Stockholders came in at $176.8 million in Q1 2026, up 121.14% year-on-year from $79.9 million in Q1 2025, and down 61.55% quarter-over-quarter from $459.8 million in Q4 2025.

Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Koninklijke Philips' Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $176.8 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 121.14% year-over-year to $176.8 million in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 678.04% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 238.88% from the prior year.
  • Net Income towards Common Stockholders slipped to $176.8 million in Q1 2026 per PHG's latest filing, from $459.8 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $485.7 million in Q2 2024 and bottomed at -$1.5 billion in Q3 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$188.9 million (2022), against an average of -$266.9 million.
  • Across the five-year window, Net Income towards Common Stockholders tumbled 522875.37% in 2022 and soared 228.83% in 2025, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$115.3 million in 2022, then tumbled by 325.57% to -$490.6 million in 2023, then grew by 27.25% to -$356.9 million in 2024, then surged by 228.83% to $459.8 million in 2025, then tumbled by 61.55% to $176.8 million in 2026.
  • Per Business Quant, the three latest PHG Net Income towards Common Stockholders figures stand at $176.8 million (Q1 2026), $459.8 million (Q4 2025), and $215.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.59 Bn 176.29 Bn 6.27 Bn 1.08 Bn
2 Stryker 129.07 Bn 126.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.58 Bn 99.36 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 68.64 Bn 67.19 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.38 Bn 44.71 Bn 1.29 Bn -
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 28.13 Bn 25.84 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.90 Bn 26.33 Bn - -
9 Koninklijke Philips 24.27 Bn 21.15 Bn 2.07 Bn 176.78 Mn
10 Steris 21.43 Bn 20.99 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 176.78 Mn
Dec 31, 2025 459.80 Mn
Sep 30, 2025 215.11 Mn
Jun 30, 2025 271.67 Mn
Mar 31, 2025 79.94 Mn
Dec 31, 2024 -356.91 Mn
Sep 30, 2024 -403.05 Mn
Jun 30, 2024 485.68 Mn
Mar 31, 2024 -1.09 Bn
Dec 31, 2023 -490.63 Mn
Sep 30, 2023 -538.85 Mn
Jun 30, 2023 -643.55 Mn
Mar 31, 2023 -711.63 Mn
Dec 31, 2022 -115.29 Mn
Sep 30, 2022 -1.52 Bn
Jun 30, 2022 -188.87 Mn
Mar 31, 2022 -170.60 Mn
Dec 31, 2021 165.88 Mn
Sep 30, 2021 566,057.91
Jun 30, 2021 36,128.14